ÄÐÈ˹¬µî

Careers Contact Locations

ÄÐÈ˹¬µî.

  • ÄÐÈ˹¬µî
  • Who We Are
    • Our Vision
    • Our History
    • Our Leadership
  • What We Do
    • Overview
    • Our Products
    • Our Solutions
    • Our Technology
    • Our Research
    • Our Diagnostics
  • News & Media
    • Press Releases
    • Announcements
    • Events
    • Presentations
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Contact
  • Locations

Press Releases

News & Media

News & Media

  • Press Releases
  • Announcements
  • Events
  • Presentations

ÄÐÈ˹¬µî Reports Third Quarter 2023 Business Highlights and Financial Results

Nov 6, 2023

New Clinical Data on ÄÐÈ˹¬µî’s RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023

Nov 2, 2023

ÄÐÈ˹¬µî to Report Third Quarter 2023 Financial Results on November 6, 2023

Oct 31, 2023

ÄÐÈ˹¬µî to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023

Oct 25, 2023

ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats

Sep 28, 2023

ÄÐÈ˹¬µî Reports Second Quarter 2023 Business Highlights and Financial Results

Aug 3, 2023

ÄÐÈ˹¬µî to Report Second Quarter 2023 Financial Results on August 3, 2023

Jul 25, 2023

FDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency

Jun 28, 2023

ÄÐÈ˹¬µî Reports First Quarter 2023 Business Highlights and Financial Results

May 3, 2023

ÄÐÈ˹¬µî to Report First Quarter 2023 Financial Results on May 3, 2023

Apr 25, 2023
RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...49
Next

OPKO HEALTH, INC.
4400 Biscayne Boulevard
Miami, FL 33137

305-575-4100
contact@opko.com

© 2023 ÄÐÈ˹¬µî. All Rights Reserved.
Privacy Policy Governance Terms of Use Sitemap